Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome – BIOMEDICINE & PHARMACOTHERAPY

Bouzas, C; Pastor, R; Garcia, S; Monserrat-Mesquida, M; Martinez-Gonzalez, MA; Salas-Salvado, J; Corella, D; Goday, A; Martinez, JA; Alonso-Gomez, AM; Fernandez-Barcelo, O; Vioque, J; Romaguera, D; Lopez-Miranda, J; Estruch, R; Tinahones, FJ; Lapetra, J; Serra-Majema, L; Riquelme-Gallegop, B; Martin-Sanchez, V; Pinto, X; Delgado-Rodriguez, M; Matia, P; Vidal, J; Cardenas-Salas, JJ; Daimiel, L; Ros, E; Toledo, E; Manzanares, JM; Gonzalez-Monge, I; Munoz, MA; Martinez-Urbistondo, D; Tojal-Sierra, L; Munoz-Bravoaf, C; Miralles-Gisbert, S; Martin, M; Garcia-Rios, A; Castro-Barquero, S; Fernandez-Garcia, JC; Santos-Lozano, JM; Basterra-Gortari, FJ; Gutierrez-Carrasquilla, L; Guillem-Saiz, P; Satorres, A; Abete, I; Sorto-Sanchez, C; Diez-Espino, J; Babio, N; Fito, M; Tur, JA – 2023 – 10.1016/j.biopha.2023.114561